Home / Transcripts / Spirax Group plc (SPX) · August 11, 2026

Spirax Group plc (SPX) Earnings Call Transcript

August 11, 2026

London Stock Exchange GB Industrials Machinery earnings 72 min

Earnings Call Speaker Segments

Nimesh Patel executive
#1

Thanks for attending this presentation of Spirax Group's half year results. I'm Nimesh Patel, Group CEO, and with me is Louisa Burdett, Group CFO. I'll start by summarizing how we performed in the first half. Once again, we've delivered a resilient set of results for the first half, and we remain on track to deliver our full year guidance. Throughout the group, our Together for Growth strategy is strengthening our differentiated business model. We're benefiting from our diversified end-market exposure and, importantly, driving growth ahead of our markets in spite of external conditions is becoming increasingly embedded in how we operate. As a result, we delivered 5% organic sales growth, well ahead of IP of 1.5%. Our organic profit growth was 6%, and the operating margin progressing to 19.8%, with EPS up 9%. We achieved this while continuing to invest in future growth. The group adjusted operating margin increased 10 basis points organically, with planned investments weighted to the first half. We invested in sales headcount, customer digital connectivity, and digital tools for sales effectiveness. Now looking briefly at the businesses. In STS, sales grew 1%, although demand growth was more than double IP. Sales were below orders as customers specified a small number of deliveries for the second half.

Nimesh Patel executive
#2

We’re bringing a solid order book and demand momentum into the second half. As expected, the drop in large project demand in China has kept easing, partly offset by additional growth in MRO and solution sales. That left China down 1%, compared with the 6% decline we saw in the first half of last year. ETS did very well, with sales up 11%, helped by strong demand growth across all three divisions and ongoing operational improvements that are raising throughput and supporting strong margin progression. At Watson-Marlow, sales rose 7%, with BioPharm new order intake ahead of sales. In Q2, orders hit the highest quarterly level since the COVID-related peak. In Process Industries, we keep outperforming IP. The lower STS margin of 22% reflects the phasing of shipments, but also investments in future growth that were more weighted to the first half. We expect a higher margin in the second half, and for the full year to be broadly in line with last year. Margins improved in ETS by 220 basis points to 17.2% through operating leverage, the mix of higher-margin sales from semicon and heat trace, and delivery of operational efficiencies. Watson-Marlow margin also improved on operating leverage by 80 basis points to 27.5%.

Nimesh Patel executive
#3

Typically, our cash conversion is lower in the first half than it is for the full year, and that reflects deliberate inventory builds aimed at cushioning possible supply chain disruption stemming from conflict in the Middle East. Return on capital employed is up 180 basis points, now above 35%. All in all, Together for Growth is delivering. We keep growing considerably faster than IP. We are taking strong order books and order momentum into the second half, and we stay confident about meeting the reiterated guidance for the full year. Now let me move to the wider demand picture. The macroeconomic backdrop was weak again in the first half. The chart on the left makes clear that IP forecasts keep being revised lower for the first half and for the second half alike, though this is largely in line with the more cautious planning assumptions we have made. The table at the top right shows the expected IP recovery has been pushed out to the second half, and the bottom right shows industrial production has stayed weak across key markets that account for roughly half of group sales. Germany is still contracting, while growth in the USA, France, Italy, and the UK stays modest at about 1%.

Nimesh Patel executive
#4

If we’re going to hit the IP forecast for the second half, then growth rates in key markets really need to step up significantly. Our approach hasn’t changed. We plan prudently and concentrate on delivering what’s within our control. IP can work against us or it can help us, especially once you get past a 2% tipping point — beyond that, we begin to see a genuine step-up in customer activity. What our performance keeps showing is that we can self-generate demand to drive organic growth. What pleases me most is that growing against tough external conditions is becoming part of how we operate — thanks to our strategy, our execution, and our investments. This makes an important point clear: our growth is linked to IP, but it does not depend on IP. The resilience of our growth rests on how broad our markets and customers are, which is a key strength of our group. Our growth potential rests on where we sit in attractive sectors that are exposed to supportive long-term growth trends, and on our capacity to take market share by focusing on solution selling. Those long-term growth trends I mean show up in all three businesses. Process optimization — what we do daily across many sectors to help customers with process reliability, energy costs, higher throughput, lower scrap, safety, essentially their efficiency and effectiveness as they meet rising consumer demand.

Nimesh Patel executive
#5

In health, we serve biotech and pharma markets, plus medical devices and hospitals—all of which gain from an aging population and innovations in healthcare. In technology, new product development is opening up applications in semicon, data centers, nuclear, and aerospace and defense, as technology reshapes how we live and work. Within ETS and STS, electrification is the trend working in our favor—that's how customers across every sector will meet their sustainability targets. Roughly 40% of group sales sit in sectors where these trends are fueling high growth, and roughly 60% sit in sectors with good growth, where we're also steadily gaining market share. Crucially, in all three of our businesses and all of our end markets, we apply the same differentiated business model to capture the opportunities in front of us. Direct sales engineers develop deep customer insight via sector focus and local presence. They know customers' mission-critical processes inside out, and applied engineering expertise lets us address customer problems and produce measurable value, with 85% of our sales coming from customers' operating budgets. That mix lets us reliably drive demand growth ahead of IP, and it's the reason we stay confident in our capacity to hit our medium-term targets—and exceed them over the long term.

Nimesh Patel executive
#6

Regarding the medium term, allow me to explain why we stay confident about hitting the organic sales growth targets established in 2024. Since we have 3 strong engines of growth, beginning with STS. Execution progress on our commercial excellence initiatives is boosting demand growth relative to IP. I'll discuss later how we are putting money into direct sales, reworking distributor partnerships, and generating growth via digital connections. China has proven a headwind to growth across the last 2 years, yet we are repositioning the business there, and as anticipated, we keep witnessing a moderation in the decline of large projects, along with strong growth in MRO. Consequently, we are on track to improve growth within our low to mid-single-digit range. At ETS, sustained strong demand across every one of our divisions plus our emphasis on operational improvements to deliver into that demand underpins our target of above mid-single-digit growth. We are delivering above that level. At Watson-Marlow, underlying market growth in BioPharm combined with our success at taking market share in target sectors within Process Industries supports high single-digit growth. Taken together, these drivers support sustaining and enhancing our mid-single-digit organic sales growth at a group level, while continuing to build on our long track record of growth ahead of industrial production.

Nimesh Patel executive
#7

Now I’ll turn it over to Louisa, who will take a closer look at how we performed financially in the first half.

Louisa Burdett executive
#8

Thanks, Nimesh, and good morning, everyone. The figures I'm giving you, as always, are on an adjusted basis, so they exclude amortization of acquired intangibles; similarly, the prior-year figures leave out costs tied to the restructuring program we carried out last year. We had no restructuring charges hit the P&L during the first half, though you'll see £5 million of cash outlay in the cash flow statement, which comes down to the timing of settlements. Just to remind you, when we talk about organic growth, we're excluding the currency-movement effect on both sales and profit as well as the impact of any M&A — and there was none of that in either this year or the prior year. First-half group performance matched our expectations and positions us well for delivering our full-year guidance. We posted mid-single-digit revenue growth, up 5% organically, which was well ahead of IP and came with growth across all three businesses. Adjusted operating profit rose 6% organically, and adjusted operating margin was up 10 basis points to 19.8%. That margin improvement came from strong performances at ETS and Watson-Marlow, partly offset by a lower STS margin, which I'll get to shortly. Adjusted earnings per share were up 9% to 150 pence per share, driven by the increase in adjusted operating profit along with stable financing costs and a stable tax rate.

Louisa Burdett executive
#9

The board has declared an interim dividend of 50.4 pence per share, which is an increase of 3%. With dividend cover back within the board's target range, future dividend growth will track underlying earnings growth more closely, while we maintain our commitment to sustainable shareholder returns and our capital allocation framework. I'll now walk you through what drove sales and profit performance, beginning with the sales bridge. Organic sales growth in the first half was 5%, well ahead of IP, and FX had a negligible impact of £1 million. All three businesses delivered organic growth. In STS, mid-single-digit demand growth translated into organic sales growth of 1%, with some shipments specified by customers for delivery in the second half. As Nimesh has already explained, China is performing as expected. ETS delivered another strong performance against a strong comparative, with organic sales growth of 11%. We are driving the demand, which is reflected in strong order books across all three divisions, including double-digit growth in semicon. Our continued operational progress in process heating also had a positive impact on throughput. In Watson-Marlow, sales grew 7% organically. As expected, new orders in BioPharm have remained above sales, benefiting from strong consumables demand, while new capacity demand is still recovering.

Louisa Burdett executive
#10

Process Industries kept beating IP by a wide margin, and we're gaining share in the sectors we target. Now on the operating profit bridge: group profit was up 6% organically, and FX gave us a 2% tailwind, which is £3 million. Starting with STS: adjusted operating profit fell 6% organically, and margin came in 170 bps lower at 22%. That's mostly a timing effect from how shipments were phased, and on top of that we deliberately put money into sales headcount and digital capabilities, weighted toward the first half. In ETS, adjusted operating profit rose 27% organically, well ahead of its strong sales growth. Margin was up 220 bps to 17.2%. What we're doing there is paying off, and the first-half margin improvement rests on each of the operational actions we have underway. As a reminder, those are strong volume growth, better operational efficiencies, no lower-margin legacy orders, and a favorable mix from higher-margin semicon and heat trace sales. Those drivers were partly offset by ramp-up costs for our new medium voltage facility and, like the other two divisions, continued investment in sales headcount and capabilities. Encouragingly, ETS posted a 20% margin in the month with the highest shipments, which shows the strong profit characteristics of this business.

Louisa Burdett executive
#11

To wrap up with Watson-Marlow, adjusted operating profit grew 11% on an organic basis, and margin rose 80 bps to 27.5%. That margin gain came from operating leverage on higher volumes plus the continued rollout of manufacturing and supply chain efficiencies, partly offset by targeted spending on sales capabilities, digital solutions, and new product development. Moving on to cash flow, adjusted cash from operations came in at £92 million, which gives a cash conversion of 54%. The softer cash flow in the first half does reflect the usual seasonality of our business, and we still expect full year cash conversion of around 90%. That said, both our absolute cash from operations and our conversion were below the first half of 2025, and that reflects the steps we took to build inventory in order to mitigate supply chain disruption we anticipated in response to the conflict in the Middle East. Capital expenditure was roughly 3% of sales, reflecting continued discipline in allocation as we prioritize investments in projects that support future growth, whilst maximizing the use of our existing manufacturing capacity. We now expect full year capex to land at the lower end of our guidance range of 4% to 5% of sales.

Louisa Burdett executive
#12

We closed out the half with net debt of £618 million and a net debt to EBITDA ratio of 1.6 times. While that sits temporarily above our target range of 1 to 1.5 times, it's not unusual given the normal cycle through the year, especially with the recent interim dividend payment, and we fully expect to be back inside this range by the end of the year as we keep our focus on deleveraging. Let me now turn to the outlook for the second half and the full year. As we've outlined, we ended the first half with strong demand momentum and healthy order books across all three businesses, which gives us good visibility and confidence in our second half delivery. Our initiatives being sponsored through our operational excellence growth driver continue to underpin sales conversion. In STS, we expect higher sales growth in the second half, driven by shipments from the strong order book at the end of the first half, which is unwinding as anticipated, as well as further progress in driving self-generated demand. We anticipate second half margin to be higher than the first half, consistent with our typical 45%-55% weighting of adjusted operating profit. This margin reflects operating leverage from higher second half sales shipments, driving a full year margin broadly in line with that of 2025.

Louisa Burdett executive
#13

For ETS, we're looking at high single-digit sales growth during the second half, even with last year's strong double-digit comparison. Strong demand and sizable order books across all three divisions back that up. Margin should come in slightly better than the first half. Then on Watson-Marlow, as we've mentioned, BioPharm orders are still running ahead of sales, and Process Industries went into the second half with a solid order book that keeps growing. For Watson-Marlow overall, we anticipate high single-digit sales growth in the second half, with margin roughly in line with the first half. A quick note on FX: if rates stayed where they are today, we'd see a negligible effect on revenue and on profit for the full year. For a bit more detail — during the first half, revenue impact was negligible while profit got a 2% tailwind. So for the second half, we expect revenue impact to be negligible once again, but profit to face a 2% headwind, and that brings you to the full year guidance. To sum up, we expect higher sales volumes in the second half, which will drive better operating leverage across the group. Along with the ongoing gains from operational efficiency initiatives, that gives us confidence in margin progression for the rest of the year.

Louisa Burdett executive
#14

We're on schedule to hit the guidance we've given for the full year. Before I wrap up, I'd like to remind everyone why our confidence is intact regarding the medium-term margin goals we laid out at our Capital Markets Day in 2024. Nimesh has already walked you through that slide and the sales drivers behind our medium-term targets, so let me now cover the margin drivers. The steps we've taken during the past two years are gaining more and more traction, as we keep holding to and meeting the expectations we set, which supports our confidence in achieving a group margin of 22% to 23% over the medium term. The rest of the path to that 22% to 23% will come largely from ETS and Watson-Marlow. Starting with ETS, we're still on track to hit our 20% margin target. The backlog of lower-margin legacy orders is now cleared, demand is still strong, operational improvements keep raising our efficiency, and our mix is gaining from growth in higher-margin semicon and heat trace sales. With lead times continuing to improve, we also see an opportunity for more value-based pricing, though we expect that to be more of a factor through 2027 and beyond.

Louisa Burdett executive
#15

For Watson-Marlow, the situation is straightforward. This is a business that has been invested in well, as we've noted previously, and the route to a margin above 30% is clear. It will be driven by operating leverage stemming from a sustained higher level of sales. And finally, at STS, we remain confident about achieving margins of 23.5% across the medium term, which we have consistently demonstrated we can do. Support for that progress will come from higher sales volumes, ongoing operational enhancements, and the advantages of organizational initiatives. When you put it all together — the strong progress we've shown in ETS, the operating leverage at Watson-Marlow, and STS's proven track record — these underpin our confidence in hitting our group medium-term margin target of 22% to 23%, while continuing to generate attractive returns on capital. Nimesh, back to you.

Nimesh Patel executive
#16

Thank you, Louisa. Now let's look at a few of the main factors behind how we performed during the first half. To begin, a quick reminder about our Together for Growth strategy. Our differentiated business model sits at the foundation. With that as the base, we're carrying out three operational priorities: commercial excellence, operational excellence, and organizational fitness. Through these priorities we're making our sales more effective, boosting manufacturing efficiency, and helping us take advantage of the scale of our group. We're also building the capacity to put money into appealing future growth opportunities, especially by way of digital and services and decarbonization, where we see considerable potential over the long term. Together, these things support delivery of our financial ambition. Turning to how we're delivering on our operational priorities. Last year, our restructuring program sharpened our organization's focus on customers in order to speed up growth, backed by reinvestment into key initiatives. We are now seeing the benefits of the changes made last year. Setting up heat trace as a stand-alone division within ETS, which benefits from dedicated sales engineers, is adding to strong growth in this high-margin part of ETS. In the same way, at Watson-Marlow, our sectorized sales teams keep building on the double-digit demand growth we saw at the end of last year in focus sectors such as mining and wastewater.

Nimesh Patel executive
#17

Within STS, that restructuring allowed us to put more money back into sales and technical capabilities, lifting headcount by roughly 3%, which helped push demand growth to more than two times IP during the first half. We're likewise seeing payoffs from the emphasis we've placed on other commercial excellence initiatives. Momentum keeps building in our co-generation approach with STS US distributors, as demand from the 22 partners onboarded in 2025 rose by roughly 6%. And data centers illustrate well how we keep widening our addressable market across all three businesses. In ETS, liquid-cooled load bank solutions present substantial opportunity, and our development pipeline there keeps growing. Demand is also showing up in heat trace for freeze protection, in STS for air eliminators, and in Watson-Marlow for specialist hoses. Taken together, these initiatives help us create demand, capture share, and deliver growth. Moving on to operational excellence. To begin, we're refining how we manufacture and supply. Within STS, we keep localizing production, shifting casting and forging work out of EMEA into China and India, and at the same time rationalizing and repricing certain lower-demand products, all of which lifts manufacturing efficiency. At Watson-Marlow, we've kept raising output at our Devens facility in the US to back strong demand, enhance operating leverage, and cut tariff exposure, while also localizing chosen production and assembly activities in APAC so lead times shorten and customers are served better.

Nimesh Patel executive
#18

Within ETS, gains in operations keep converting straight into expansion and better margins. Thanks to increased throughput and reduced lead times, shipments of large medium voltage heaters were over twice as high during the first half. We likewise met semicon demand successfully, with shipments rising by another double-digit percentage. Our operational focus builds the capacity needed to put money into the opportunities underpinning future growth. On the digital and services side, we keep reinforcing customer ties by linking ever more closely to customers' processes, and I'll go into more detail about that on the following slide. To begin with decarbonizing thermal energy, we're still advancing across all four of our go-to-market strategies. At STS, our Sustainability Centre of Excellence — set up as part of restructuring — won orders successfully to carry out steam system audits at 80 sites for several multinational food and beverage clients, aimed at pinpointing chances for energy optimization. Over in ETS, we landed 10 Powering Zero orders in the first half, worth roughly £12 million in total. We're also tapping further into the joint expertise of STS and ETS via our thermal energy assessment capability. Across the first half, we completed 16 assessments in the USA, Europe, and China, which helped customers find meaningful energy savings and opened up considerable potential pull-through revenue opportunities averaging more than five times the original assessment revenues.

Nimesh Patel executive
#19

All of this investment is making our customer partnerships stronger, widening the market we can serve, and underpinning durable organic growth over the long term. Let me take a moment to walk through the opportunity we see in digital. In recent years, we've put money into building out our connected products and service capabilities so that we can offer a digital proposition that stands apart, backed by small bolt-on acquisitions like Cotopaxi Energy Management Solutions and Pulse sensing technology. That capability is now helping us become more deeply embedded in the processes our customers consider critical, shifting us away from periodic walk-the-plant reviews and toward delivering continuous insights, data, and recommendations customers can act on. At present, we physically survey roughly 1 million traps each year, and that figure doesn't even represent our full installed base. Based on what we've learned and our expertise, connecting approximately one in 10 steam traps within a steam loop is what's needed for us to construct a system-wide view. Naturally, knowing which traps should be connected depends on our sales engineers' understanding of each customer's individual systems and mission-critical processes, along with how those systems actually run day to day. In STS, we currently have 19,000 connected steam traps spanning 2,350 customer sites, all of them added since 2023. We aim to go past those 19,000 traps — first to 100,000 — while also keeping in mind that this figure represents just a portion of our expanding installed base and a small fraction of the industry's installed base.

Nimesh Patel executive
#20

With the investments we've made, we're on course to achieve exactly that. In addition to revenue from connected products and digital subscriptions, our connections generate considerable extra value. Through spotting chances to optimize, maintain, and replace, we produce pull-through revenue and at the same time help customers enhance their reliability, efficiency, and sustainability. Take a dairy customer that runs with throughput that varies a great deal and has narrow maintenance windows. They shifted from physical annual steam trap surveys, which spot failed traps at a single point in time, to continuous wireless monitoring throughout their steam and condensate loop. Failures are now identified by our solution as they happen, which cuts energy losses and saves roughly £100,000 annually for that customer, while also enhancing maintenance planning and giving them a short payback. Our digital potential excites us, and we keep evolving and adapting so that we maximize the opportunity. To recap before we go to Q&A: once again we have delivered on the expectations we laid out. Even with the challenging macroeconomic backdrop, we achieved resilient mid-single-digit organic growth in both sales and profit, well ahead of industrial production. We're confident in our capacity to deliver in the second half. Strong order books and ongoing momentum across our end markets give good visibility into growth and margin progress.

Nimesh Patel executive
#21

To wrap up, a final note that our unwavering emphasis on getting things done and managing what we can control is paying off, and we're making that approach of growing faster than our markets part of how we operate day to day. Because of this, we're still on course to hit our medium-term targets and to exceed them over the long term. Thanks. We're glad to take your questions now.

Mal Patel executive
#22

Good morning, everyone. Mal here. Thanks for sending in your questions online. Just a reminder that you can continue to do so until the call finishes. I'll read your questions aloud exactly as they appear on the screen. The first one comes from Stefan about STS. Could you explain what you meant when you said larger orders are returning? Since demand for these has been missing for some time now, will that result in sales speeding up going forward?

Nimesh Patel executive
#23

Thank you, Stefan. That's a good question. We discussed this during our previous trading update, and it has come up once more in the half year results. You're correct that we are observing what I'd call a modest increase in large orders within our steam business. Keep in mind that this comes off a weak comparator, yet it is an encouraging indicator of customer activity and one of the pillars supporting the longer-term growth increase of STS. Maybe I should take a moment to address the longer-term growth potential of STS. Let me begin by reminding you of the recent backdrop. We have been posting roughly 3% to 4% growth excluding China, which has acted as a headwind, and we achieved that against a low IP of approximately 1.5%. Several items have held our focus. The first is repositioning our business in China, which is moving forward very well, as we are updating you on in these results. During the first half, China declined 1% owing to the moderating decline in large orders, but also to continued strong growth in MRO and solutions. China is likely to return to growth. We have spoken about reaching an inflection point in either late this year or the early part of next year, and I can see a path for China to grow at least in line with the remainder of the global STS business, and perhaps better.

Nimesh Patel executive
#24

Once that occurs, steam returns to roughly a 3% to 4% growth rate. Beyond that, we have investments boosting steam's growth in both digital and decarbonization, which is why I wanted to devote some time today to the digital opportunity. My view is that digital and decarbonization together contribute 1% to steam growth, bringing us to 4% to 5%. Another point worth noting: none of this includes any improvement in IP, and bear in mind we grow at two times IP, so you can see how that might lift growth even more. Last, keep in mind the long track record we have in steam, backed by our capacity to self-generate growth. We now have a business that is also well invested in both our sales capability and our supply capacity. Thank you for the question.

Mal Patel executive
#25

Stefan has another question about ETS. Could you comment on that 20% margin target? Should we take it as a target for the full year, or is it an exit rate? And to reach it, are we correct in assuming that pricing initiatives need to help, something you haven't done in past years?

Nimesh Patel executive
#26

I'll start us off, and then, Louisa, I'll pass it over to you. We have confidence in our capacity to reach the 20% target for ETS. Louisa offered a genuinely compelling piece of evidence regarding the quality of this business from a margin standpoint — specifically, we achieved 20% during one month in the first half of the year, and that particular month happened to be when we shipped our highest value of product. That isn't a surprise, since we've discussed what drives us toward 20%, and volume along with continued demand growth is one of those drivers. Louisa, would you like to take that question?

Louisa Burdett executive
#27

I'd like to echo what Nimesh said. That 220 bps of margin improvement in the first half is genuinely pleasing, and as I mentioned, it rests on demand growth, efficiencies, mix, and the absence of those legacy orders. Across every one of our business units we price for value, and ETS is no different. Stefan, parts of that are already built into our business model. Once we're fully past some of our lead time and efficiency improvements, we believe there's additional pricing opportunity, so we should see more of it after the 2027 period — but we aren't sitting and waiting, since our competitive position in this market is particularly strong; it's a continuum. On delivery, as Nimesh said, we're confident about hitting that 20% margin, and we hope today has given you some solid proof points.

Mal Patel executive
#28

Good. Moving on, we've got three questions from Chet at JPMorgan. First, can you give us some additional detail on the more than two times IP order momentum that you're seeing in STS, and do you now see a likelihood of China being neutral in H2 rather than early 2027? Second question, this is the first time we've heard you discuss end-market exposures. Does that mean you could move away from IP as a significant driver of the business? If so, how should we think about the longer-term growth algorithm? Finally, on ETS, semis grew a double-digit percentage. How sustainable is that, and what visibility do you have?

Nimesh Patel executive
#29

You may need to jog my memory on a few of those questions once we reach them. I'll begin with the first one, which concerned demand growth in STS. In the first half, we observed IP demand growth of more than 2x. IP came in at 1.5%, which means that figure is above 3%. Incidentally, keep in mind that the ongoing conflict produced a minor effect on demand in the Middle East. The Middle East accounts for 1% of group sales, yet it carries a much heavier weighting toward steam than the remainder of our businesses do. Strip out the Middle East effect, and the demand growth generated by the rest of the world was even stronger than what we are discussing here. I am genuinely quite pleased with the demand growth we achieved in steam during the first half. The second point I would make is that what you should take away from this is that orders are clearly running well ahead of sales. As we move into the second half, we have not only a healthy order book — and remember, we are not a business with significant coverage from our order book when you look several months ahead — but that order book underpins our confidence as we enter the second half.

Nimesh Patel executive
#30

What matters even more is that the momentum in orders is what gives us confidence as we head into the second half. Naturally, as we sit here today, we can already see what took place in July, and our flash data gives us indications of what is happening in August. As stated in our release, we are already witnessing the expected unwind of those order books, which is driving sales growth, along with continued demand for orders. That gives us confidence in the second-half performance of steam, precisely as we have described it. Earlier, in response to Stefan's question, we discussed the large orders returning, which is very early stage against a weak comp, but it is still a positive sign. Keep in mind the sales performance in the first half, which in turn has some effect on the margin along with the investments—we are talking about small numbers. 1% of steam in the first half is roughly £4 million. That is literally the equivalent of a few days' worth of shipments. It probably helps to put a little bit of that into context. The second question concerned sector exposure. My memory is not failing yet.

Mal Patel executive
#31

On the sector exposure question, is that a signal that IP will likely stop being a driver for you, and what are the implications for the longer-term growth algorithm?

Nimesh Patel executive
#32

Our company operates across a number of industries and in many parts of the globe. Nearly every sector uses all of our technologies in one way or another. It's unavoidable that industrial production activity will drive our business growth. With more activity, we'll sell more consumables, more maintenance will be needed, demand will grow further, and there will be a bigger call on our solutions to support process effectiveness, cut waste, and drive higher throughput. All of these things are tied to IP in some manner. That said, I've also noted that although we can't be entirely separated from IP, what we can do is keep enhancing how much we outperform IP. Once again, in the first half we achieved organic sales growth of 5% at group level in a world where IP is 1.5%. We have real volume growth in this year's first half. That comes from the changes we've implemented via our Together for Growth strategy and through our restructuring — we are pursuing the opportunities we see. What I wanted to remind everyone of with the sector exposures slide was, first, we are diversified and present across a number of sectors; second, a very significant share of our sales sits in sectors that are very exciting and high-growth; and third, we are generating good growth and gaining market share beyond that in other sectors thanks to our capacity to self-generate demand and provide solutions to our customers.

Nimesh Patel executive
#33

I hope that came through clearly.

Louisa Burdett executive
#34

I might take Chet's remaining two questions — I believe that was regarding China progression coming in as neutral?

Mal Patel executive
#35

Semis.

Louisa Burdett executive
#36

Semicon is definitely a high-growth industry for us. To build on what Nimesh said about customer solutions, we're seeing double-digit growth in that sector. Our ties with customers are strong, and we have really good visibility into what that pipeline looks like. It's a solid high-growth area for us — one where we're closely connected with our customers and responsive to their needs.

Mal Patel executive
#37

Apologies — regarding Chet’s second question, that second part concerned China. At this point, do you expect it to be neutral in the second half?

Nimesh Patel executive
#38

We are definitely more confident that China will reach that neutral point, based on how things went in the first half and what we can see heading into the second half. We have consistently said the range was the second half of this year or early the following year. It seems fair to say that it could very well arrive toward the earlier end of that range instead of the later end. There is still more water to flow under that bridge.

Mal Patel executive
#39

Besik from Lombardi Capital has a question. Could you put a number on how much of a headwind STS's first half organic growth faced because of the client-driven shipment phasings that moved into the second half?

Nimesh Patel executive
#40

To put it in broad terms, what we're facing is a headwind amounting to the low single-digit millions of pounds. This ties back to the point I made about the law of small numbers. For steam, 1% of growth in the first half works out to roughly £4 million. Those orders are visible to us, we can see them sitting in our order book, we can see that customers have specified shipment in the second half, and we can see when in the second half they're going to ship. As I mentioned, during the first couple of months of this second half, we've already witnessed that order book unwind. Frankly, things are moving forward exactly in line with what we laid out in our results.

Mal Patel executive
#41

We have a few questions coming from Rory at OxCAP. First, could you put a number on the strong growth we're seeing in STS MRO activity in China? And could you remind us what the margin gap is between STS MRO and project activity in China?

Louisa Burdett executive
#42

Rory, hello. Double-digit expansion in MRO has kept going, just like it has over the past couple of periods, and clearly that's a major force behind China's overall STS coming back to -1% from -6% in the previous period. On top of that, the drop in large orders has eased, which has certainly contributed. We've consistently said, in a directional way, that MRO margins run a bit above large order margins in China, though we haven't given a specific quantification. Basically, with MRO growing and our ongoing emphasis on large orders, our China business gets even better, and as we've said all along, it stands out as one of our best OpCos at reading the market and pivoting, and that balance between MRO and large orders leaves it a stronger business overall.

Mal Patel executive
#43

Rory's second question — what supply chain effects are we observing originating from the Middle East? Is that the reason customers have pushed shipments into the second half, or does that involve a separate dynamic?

Nimesh Patel executive
#44

Now, regarding the shipment delays that have pushed into the second half — and once again, I want to remind everyone that these involve relatively small numbers. We've observed this among customers in the Middle East. Obviously, it is difficult and potentially unsafe to reach customer sites in certain parts of the Middle East, and the safety of our colleagues comes before everything else. That said, there's an opportunity here: once it becomes safe to work with our customers and access their sites, we'll have a chance to support repairs, maintenance, ramp-up, and various other activities at our customer sites. That could represent upside in the second half of the year. As for other deferrals, there are customers in other regions of the world who have been watching what's happening in the Middle East, and also more broadly around the globe, and deciding how to phase their investment over the year. Some projects they may have intended to execute in the first half have shifted into the second half. We've got the orders, we know when we need to ship the projects, and we're confident that demand will come through. On the first part of your question, which concerned disruption to supply chains, we acted prudently and early to ensure we could keep supporting our customers with their needs.

Nimesh Patel executive
#45

Looking ahead, I think supply chain disruptions will be limited, and in the places where we expect them to persist, we already have plans ready. So because of that, we'd anticipate bringing down inventory levels that are above normal over the second half of the year, and that is what will show up as better cash conversion in that same second half.

Mal Patel executive
#46

And lastly, Rory here, on ETS — it really seems like ETS is at last turning a corner. Regarding headwinds, with the incremental medium voltage ramp-up costs at Ogden, given the strong demand you're seeing, or had you always anticipated incurring these costs during this period? And as a follow-up, do any opportunities open up for you as data center architecture moves toward medium voltage?

Nimesh Patel executive
#47

ETS has put up a strong performance over the past couple of years. Naturally, that improvement program isn’t something that can be delivered overnight, even though I, more than anybody else, wish that it could be. I have to say, I believe the team there is doing a phenomenal job of pursuing the opportunities. I think there are 2 aspects to that. First, on growth, you can see the strong demand growth that we’re generating in ETS year in, year out. Second, there’s the ability to deliver operationally against that growth, whether that means tackling some of the historic operational issues that existed around large projects in particular coming out of our North American factories. As a reminder, in the 5 years to our Capital Markets Day in 2024, output from those factories in North America was down around 10% in volume. Since then, it’s up over 40% in the last what now, 2.5 years. I’m really pleased with that performance. In turn, as Louisa described earlier, that continued demand growth, that ability to deliver it to customers, and the efficiency improvements that we are making are driving margin improvement, and obviously we’re not done yet, because we’re going to get the margin to 20%. I have absolute confidence that this business can be a 20% margin business.

Nimesh Patel executive
#48

Feeling genuinely good about how things are going on that front. My apologies — could you remind me what the latter half of your question was?

Mal Patel executive
#49

Right, and then the second item concerned data centers. We'll get to that shortly, since there's another question about the ETS margin. This one comes from Andy at Jefferies. Given that you've already reached the 20% margin target for ETS in the first half — and that's before any pricing — is that goal now too low?

Nimesh Patel executive
#50

Andy, you're right that it doesn't include pricing. Pricing is an upside. If I respond to a somewhat different question than the one you posed, then you can hold me accountable if my answer doesn't sit well with you. This business can achieve margins above 20%. Of that I'm certain. For us as a management team, the question is how to weigh a higher margin against more investment in sustaining and enhancing this business's longer-term growth. Our view is, look, let's reach 20%, but once we're at 20%, there are some genuinely interesting incremental opportunities — even beyond what we're doing today — for investing in this business's longer-term growth. That isn't holding us back today, but as I look out 5 years, 10 years, and beyond, I think these are investments that will really help us keep doing, as I say, both sustaining and enhancing high levels of growth from ETS. We'll make those judgments once we reach 20%, and we'll decide whether we think that margin could be a little bit higher, another 100 basis points or so, or whether we think we should put that money back into investing in longer-term growth?

Nimesh Patel executive
#51

It's quite evident to me that putting money into growth over the longer term, along with the compounding character of the returns that this generates, is appealing for the people who invest with us.

Mal Patel executive
#52

Max from Morgan Stanley has two questions. First, regarding steam, please expand on the margin performance you anticipate in the second half, and what the key levers are as you move from a first-half decline to a second-half recovery? Second, on Watson-Marlow, orders and end-market momentum point to another year of strong growth in Watson-Marlow into 2027. Is there any reason we couldn't keep going at the circa 50% incremental margins into 2027? Are there any investment areas needed in the business that might dampen operational leverage into 2027?

Nimesh Patel executive
#53

Would you like to handle that one, Louisa? Just to remind everyone, our first-half margin rose 10 basis points on an organic basis. That opening question, I believe, is specifically about STS's. Louisa, would you like to take it?

Louisa Burdett executive
#54

Max. That robust order book we've discussed for steam — two times IP in the first half — is among the forces behind our second half sales growth, and we've been clear that what we're seeing in July's performance shows that unwind. As Nimesh mentioned, the team's capacity to keep generating demand will also support second half sales growth. Naturally, that stronger sales growth hands us more operating leverage than we had in the first half, which brings a margin benefit, and we've discussed the fact that we directed more investment into the first half toward our commercial excellence initiatives, which is plainly delivering a return in the order book, but we expect that investment level to taper off in the second half, and that will be one more addition to STS margin in the second half. I think on Watson-Marlow, we've always said Watson-Marlow is well invested. We've discussed investment on America's East Coast at our Boston facility, along with the Falmouth facility in Cornwall, and all the operational excellence initiatives we're pursuing in Watson-Marlow, in common with the rest of the business.

Louisa Burdett executive
#55

So we're going to keep putting money into developing new products. Initiatives such as Watson-Marlow Architect have been hugely successful for us. What Nimesh said about ETS holds true for Watson-Marlow as well: we have to balance that investment so this important division keeps delivering compounding growth. As for big facility investments, we don't see much of a need right now; at the margins we'll keep investing, but the underlying growth algorithm and the drop-through are still intact.

Nimesh Patel executive
#56

Let me build on what you said regarding the investments we made during the first half in steam—whose effect you are already seeing on margin, though the margin improvement will show up in the second half. Just to give you some sense of what those investments are: as we mentioned last year, following the restructuring, we wanted to plough the savings back into building and, to some degree, rebuilding. At the Capital Markets Day in 2024, I spoke about how we needed to step up investment in steam to drive long-term growth, particularly by rebuilding our sales capability. Into the steam business we have brought roughly 100 sales and technical colleagues. Now, clearly, between realizing the benefits from the restructuring and then finding those people, getting them on board, and having them on payroll, there is a bit of a lag in the reinvestment. That is why the run-rate cost of those people is coming through in the first half of this year rather than last year. We have also directed more money toward cyber and IT, and toward our digital connections as well, which I described earlier in my presentation. Those are the areas that have received the investment.

Nimesh Patel executive
#57

On the plus side, we have rebuilt that. Yes, it will take a while before some of those people deliver the full return on the investment, since a sales engineer typically needs two to three years to reach a sort of full run-rate delivery. That said, our investment is now complete. We are largely done. I am not seeing any significant or material new investment in the second half of this year. When you look at the order book we have, the order momentum we have going into the second half, as I said, we are already starting to see the benefits of that in July and August, together with the investments we have already made with no new investments coming through, the second half drop-through for steam is high, and that is why we have confidence in the margin guidance that we shared today.

Mal Patel executive
#58

We've got a few questions coming from Jonathan Hearn at Barclays. First, what did the cost underabsorption tied to the ramp-up of new capacity at Ogden come to during the first half? Will that decrease in the second half, and does it go away entirely in 2027? Would you like to take that one, and then we'll continue?

Louisa Burdett executive
#59

Jonathan, that's a small offset compared with the other positive drivers in ETS, mainly because we have a new facility that isn't at capacity yet, so fixed costs are being absorbed across fewer units — over a smaller number of units, I should say. As Nimesh mentioned, we've provided you some metrics on how productivity across the entire Process Industries production environment is rising. We did expect some degree of underabsorption of fixed overheads, and we'll likely see a bit of that in the second half and perhaps into 2027. It really comes down to the mix we get in ETS. Look, we've delivered 10% sales growth sequentially, then 12% sales growth, then 11% sales growth, and this machine is beginning to get much more productive, and as that capacity ramps, we will reach normality on unit cost coverage. I can't give you a specific date for when it goes away. Then

Mal Patel executive
#60

Following up on ETS, again from Jonathan: during the first half, by how much did heat trace and semicon margins exceed the ETS average? Just

Nimesh Patel executive
#61

Jonathan, to put it plainly, margins in heat trace and semicon are above 20% — I'd call it a bit above 20%. As Louisa just explained, we're working toward better margins in the process heating portion of our business, and that portion accounts for roughly 60% of ETS overall.

Mal Patel executive
#62

Jonathan has a couple more questions. Did project shipments also play a part in that 1% decline in sales in China?

Nimesh Patel executive
#63

Right, since what we're observing is large orders declining more slowly rather than actually growing yet, that's going to factor into the impact on the 1%, and naturally, it gets offset by growth in MRO and solution sales.

Mal Patel executive
#64

We've received several questions about Watson-Marlow, and I hope you'll excuse me if I bundle them together, since all of you have raised the same point. What were the growth rates for Process Industries and BioPharm within Watson-Marlow, and could you walk us through the difference in margin between Process Industries sales and BioPharm sales?

Nimesh Patel executive
#65

Let's address the second question first, since it's the simpler one. Margin-wise, Process Industries and BioPharm aren't meaningfully different. Basically, we supply peristaltic pumps, specialty hoses, and even single-use consumables across a range of sectors — food and beverage will consume single-use items just as BioPharm does — and there's no material margin gap between Process Industries and BioPharm. On growth rates, we haven't put specific numbers on the individual growth rates, but what I think you can take from the results is that we delivered 7% organic growth in Watson-Marlow sales. We've said that orders exceed sales, and just to add a bit more color that's helpful on BioPharm, what we're observing — and forgive me if this sounds boring, though that's probably reassuring, or at least it should be — is that the end-user demand I've been discussing keeps performing well, and in particular, we're seeing consumables pull through as those end users are essentially drawing on their existing capacity and getting the most out of the capacity they already have. Where we still see a gradual recovery — and remember, back in 2024 I described this as a U-shaped, gradual recovery — is in new expansion activity.

Nimesh Patel executive
#66

That's still coming back gradually, so new capacity is being built, though not at the pace we saw before. That said, the project pipeline is visible, and we can see it recovering. Keep in mind this really concerns larger customers adding that capacity. Actually, several of those customers are moving their investments around — one notable pattern is money flowing out of the UK and out of Germany and heading into the US and into China too. We're very well placed to capture that demand no matter where it lands. Whether it's EMEA, APAC, or the Americas, we'll capture it. When projects get moved from one region to another, delays do result. We feel quite good about BioPharm demand, and as one more reminder, during this year's second quarter we recorded the strongest quarter for BioPharm orders since COVID. That was a peak for us and, once again, just more evidence that this space keeps recovering.

Mal Patel executive
#67

Emmanuel from Kepler has a question on STS. Could you provide more detail on how much of the second-half revenue and margin recovery is already locked in through the existing order book? And with your cautious stance on the IP recovery, would you still expect to hit full-year guidance if IP stays around first-half levels instead of improving?

Nimesh Patel executive
#68

Starting with the IP question — basically, yes, since we've adopted a more cautious stance on how IP will perform in the second half. There's added nuance there, of course, because it clearly hinges on which IP lines are rising and which are falling, yet at bottom we aren't counting on any meaningful IP rebound to hit our figures. The second thing, answering the first portion of your question — apologies — concerns our order books, since we typically book and ship roughly 40% during the month and somewhere between 80% and 85% inside 3 months, so order books won't really hand you much visibility as we head into the second half. What they do provide is reassurance that, right away — given the stronger order book position at the close of the first half — there's at once a set of shipments we can identify that has rolled into the second half. That's a plus. As I mentioned before, the other element we keep observing is order momentum carrying over from the first half into the second half, and that's precisely why we feel confident about delivering second-half growth in steam.

Nimesh Patel executive
#69

Like I mentioned before, because of the investments we made right at the end of last year and then early this year — you're seeing the run-rate effect of those in the first half — and since those investments won't be going up from here, we can also see the strong drop-through in the second half for STS, which gives us confidence on margin. As a reminder, and this is very much typical of the old Spirax, the sales split between H1 and H2 that we're looking at is 48%-52%, first half, second half, and the profit split we're looking at is 45%-55%. That's not unusual for our business in terms of seasonality.

Mal Patel executive
#70

Martin Wilkie from Citi has a question. Regarding semiconductors for ETS, if China makes progress on lithography equipment developed domestically, is that end market accessible for ETS to supply into? And could you remind us how semiconductor exposure within ETS currently splits?

Nimesh Patel executive
#71

Equipment heating accounts for roughly 25% of ETS sales, and semicon makes up half of that — so you're looking at about 12.5% of sales. Those figures are for 2025, and we've seen strong growth since then; they'll move a bit for this year, rising in semicon. On the APAC question, we're collaborating with customers to build an even stronger footprint in the APAC region so we can serve them. Here I mean broadly international customers — US and European. We're also expanding our presence in China so we can serve the domestic market. The advantage we have is that in the spaces where we play — and just to remind you, that's atomic layer deposition, lithography, and etching, all parts of the wafer fabrication equipment process, all different kinds of wafer fabrication equipment across the process — those areas where we play carry very specialized, highly technical requirements around electrical thermal energy in those processes. That demands a high level of expertise and R&D, and we are very, very well positioned to solve our customers' problems. It's not clear to me that such expertise exists elsewhere in the world or inside other companies.

Nimesh Patel executive
#72

The number of competitors here is fairly limited, and that, in turn, lets us go after that business and hold our own in China. I don't want us getting complacent about it. There's work ahead of us, money that needs to be invested, capabilities we have to develop inside China to capture that demand, and naturally, when all is said and done, some regulatory limits may exist that we'll need to keep in mind. Structurally, nothing prevents us from competing.

Mal Patel executive
#73

I believe there's room for a couple more questions to wrap up, and as it turns out, both concern capital allocation. The first comes from Emmanuel at Kepler: do you view M&A as a significant driver of growth across the medium to long term? Next, from Varun at Exane: what conditions would have to be in place before you'd pursue a share buyback, considering the strong free cash flow you expect and where your equity currently trades in the market? At what point would a buyback be something you'd consider?

Nimesh Patel executive
#74

Would you like me to handle the first one, Louisa, and for you to take the second?

Louisa Burdett executive
#75

Absolutely, that works.

Nimesh Patel executive
#76

On the first question, absolutely — bolt-on acquisitions fit within how we think about allocating capital. I'd say we've reached a stage where we've shown we're delivering — not fully delivered yet, but delivering — the value from the ETS acquisitions, and we've shown the success we've had with quite a few small bolt-ons such as Cotopaxi, such as Pulse, and some of the smaller distributors we purchased in steam, even if that was a couple of years back. So we're confident in our capacity to spot the right targets, bring them in at the right valuations, generate high returns from those acquisitions, speed up our organic growth, and lift the margins on the businesses we buy as well. When it comes to small bolt-ons, I'd say those are very much on our agenda, and we're devoting time and effort to finding those targets. We'll stay highly disciplined — we've examined a number of opportunities where multiples are high and returns are therefore low, and we'll walk away from those, and we always benchmark those opportunities against other uses of capital, one being our ability to invest more money in new product development and thereby accelerate growth that way, and another obviously being buybacks.

Nimesh Patel executive
#77

Louisa, I'll pass that part over to you.

Louisa Burdett executive
#78

At the close of 2025, we made our capital allocation framework clearer, and picking up on what Nimesh said, our view remains that putting money back into organic opportunities—along with the inorganic ones Nimesh just described—is the strongest route to compounding growth for this business. We've likewise been explicit that should we reach the low end of our leverage range, which we publicly put at 1 to 1.5 times, and if attractive opportunities capable of delivering the kinds of returns we're after aren't available, then at that stage we would clearly be looking at a buyback.

Mal Patel executive
#79

All right, thank you, everyone. That covers the questions.

Nimesh Patel executive
#80

I really appreciate all of you taking the time to be with us. We’re looking forward to catching up with you before long. Thanks so much.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Spirax Group plc transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Spirax Group plc earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.